ES2072430T3 - Reduccion de las concentraciones post-prandiales en plasma de aminoacidos neutros grandes. - Google Patents

Reduccion de las concentraciones post-prandiales en plasma de aminoacidos neutros grandes.

Info

Publication number
ES2072430T3
ES2072430T3 ES90905824T ES90905824T ES2072430T3 ES 2072430 T3 ES2072430 T3 ES 2072430T3 ES 90905824 T ES90905824 T ES 90905824T ES 90905824 T ES90905824 T ES 90905824T ES 2072430 T3 ES2072430 T3 ES 2072430T3
Authority
ES
Spain
Prior art keywords
amino acids
prandial
neutral amino
post
plasma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90905824T
Other languages
English (en)
Inventor
Richard J Wurtman
Judith J Wurtman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Indevus Pharmaceuticals Inc
Original Assignee
Interneuron Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Interneuron Pharmaceuticals Inc filed Critical Interneuron Pharmaceuticals Inc
Application granted granted Critical
Publication of ES2072430T3 publication Critical patent/ES2072430T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Pediatric Medicine (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Treating Waste Gases (AREA)

Abstract

METODOS DE REDUCCION DE LAS FLUCTUACIONES POST-PANDRIALES EN LOS NIVELES DE PLASMA DE AMINOACIDOS LARGOS Y NEUTROS (LNAA), AL IGUAL QUE COMPOSICIONES UTILES EN ESTE METODO. LOS ALIMENTOS Y COMPOSICIONES INCLUYEN UNA PROPORCION DE CARBOHIDRATOS A PROTEINAS DE CERCA DE 3:1 HASTA CERCA DE 6:1, Y EN UN CONTEXTO ESPECIFICO UNA PROPORCION DE 4:1, LO CUAL RESULTA EN LA MINIZACION DE LA VARIABILIDAD EN LAS RESPUESTAS INDIVIDUALES EXHIBIDAS EN DROGAS QUE SON LNAA.
ES90905824T 1989-04-03 1990-04-02 Reduccion de las concentraciones post-prandiales en plasma de aminoacidos neutros grandes. Expired - Lifetime ES2072430T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/332,871 US5206218A (en) 1989-04-03 1989-04-03 Reducing post-prandial fluctuations in plasma concentrations of large neutral amino acids (lnaa)

Publications (1)

Publication Number Publication Date
ES2072430T3 true ES2072430T3 (es) 1995-07-16

Family

ID=23300218

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90905824T Expired - Lifetime ES2072430T3 (es) 1989-04-03 1990-04-02 Reduccion de las concentraciones post-prandiales en plasma de aminoacidos neutros grandes.

Country Status (9)

Country Link
US (1) US5206218A (es)
EP (1) EP0466769B1 (es)
JP (1) JPH04506597A (es)
AT (1) ATE119353T1 (es)
CA (1) CA2050585A1 (es)
DE (1) DE69017673T2 (es)
DK (1) DK0466769T3 (es)
ES (1) ES2072430T3 (es)
WO (1) WO1990011696A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5698525A (en) * 1989-04-03 1997-12-16 Interneuron Pharmaceuticals, Inc. Reducing post-prandial fluctuations in plasma concentrations of large neutral amino acids (LNAA)
US5432162A (en) * 1989-04-03 1995-07-11 Interneuron Pharmaceuticals, Inc. Reducing post-prandial fluctuations in plasma concentrations of large neutral amino acids (LNAA)
CA2131801A1 (en) * 1992-03-11 1993-09-16 Richard J. Wurtman Reducing post-prandial fluctuations in plasma concentrations of large neutral amino acids (lnaa)
US5393784A (en) * 1993-07-21 1995-02-28 New York State Office Of Mental Health Treatment of tardive dyskinesia with leucine, isoleucine, valine or mixtures thereof
US5670539A (en) * 1993-07-21 1997-09-23 New York State Office Of Mental Health Treatment of movement disorders using large neutral amino acids
IE80469B1 (en) * 1993-09-13 1998-07-29 Elan Corp Plc Compositions for reducing fluctuations in plasma concentrations of large neutral amino acids and use thereof in therapy
US5480865A (en) * 1994-02-25 1996-01-02 Parkinson's Charitable Trust Nutritional composition
US5595772A (en) * 1995-06-07 1997-01-21 Massachusetts Institute Of Technology Composition and methods for losing weight
EP1073345B1 (fr) * 1998-04-23 2007-10-24 Pro Dietic RDP (S.A.R.L.) Complement proteique, composition alimentaire le contenant, leur procede de preparation et leur utilisation
FR2777751B1 (fr) * 1998-04-23 2001-11-02 Pro Dietic Rdp Complement proteique, composition alimentaire le contenant, leur procede de preparation et leur utilisation.
US20060257469A1 (en) * 2005-04-05 2006-11-16 Bulka Yochanan R Enhanced indoleamine and catecholamine bio-availability via catechin inhibition of L-Dopa decarboxylase

Also Published As

Publication number Publication date
DE69017673T2 (de) 1995-07-06
CA2050585A1 (en) 1990-10-04
JPH04506597A (ja) 1992-11-19
DE69017673D1 (de) 1995-04-13
EP0466769B1 (en) 1995-03-08
ATE119353T1 (de) 1995-03-15
DK0466769T3 (da) 1995-03-27
US5206218A (en) 1993-04-27
EP0466769A1 (en) 1992-01-22
WO1990011696A1 (en) 1990-10-18

Similar Documents

Publication Publication Date Title
ES2072430T3 (es) Reduccion de las concentraciones post-prandiales en plasma de aminoacidos neutros grandes.
DE69027865T2 (de) ZUSAMMENSETZUNGEN enthaltend omega Conotoxin Peptide Derivate und deren Verwendung ZUR BEHANDLUNG VON ISCHÄMIE-ARTIGEN NEURONALEN SCHÄDIGUNGEN
CA2259761A1 (en) A continuous process of dynamic high-pressure homogenization for the denaturation of proteins
BR9407047A (pt) Processo para separaçao de uma proteina de uma soluçao aquosa de proteinas
ES2065911T3 (es) Produccion de proteinas en formas activas.
IT1203873B (it) Composizioni farmaceutiche che lo surfattante polmonare naturale, contengono. metodo di preparazione e
ATE388137T1 (de) Aminosäurederivate und süssungsmittel
CO4960626A1 (es) Producto similar a mayonesa y procedimiento para su elaboracion
CA2184262A1 (en) Hygienic and cosmetic preparations for preventing and treating skin-diseases as well as a process for obtaining same
AR240065A1 (es) Metodo para la hidrolisis de proteina de grado alimenticio e hidrolizado de proteina de soja obtenido por dicho metodo.
ATE131471T1 (de) An fette gebundene aminosäuren, peptide oder deren derivate
ES2148813T3 (es) Procedimiento para la elaboracion de plantas que contienen proteinas.
DE69129747T2 (de) In lösung bringen von proteinen in aktiver form
DE69508890D1 (de) Verwendung eines Dekapeptids mit benzodiazepinischer Wirkung zur Herstellung von Arzneimitteln und Diätzusätzen
DK0406216T3 (da) Protein-S-holdigt farmaceutisk præparat
DE3762792D1 (de) Schwarztrueffelaroma.
ES2063161T3 (es) Proteinas modificadas.
DK0538690T3 (da) Arylquinolyl-substituerede 1,4-dihydropyridin-dicarboxylsyrederivater, fremgangsmåde til deres fremstilling af deres anvendelse i lægemidler
FR2637593B1 (fr) Nouveaux derives de la carbonyl-2 n,n(prime)-di-(trimethoxybenzoyle) piperazine, ainsi que leur procede de preparation
BR9004693A (pt) Solucao aquosa,processo para aumentar a concentracao de proteina de uma proteina em uma solucao aquosa,e composicao farmaceutica
EA199600048A2 (ru) N,n-диэтил-8,8-дипропил-2-азаспиро[4,5]декан-2-пропанамин дималеат, фармацевтическая композиция на его основе и способ индуцирования иммуномодуляции
ES2110671T3 (es) Procedimiento para la separacion de l-leucina y l-isoleucina de soluciones acuosas.
FR2637592B1 (fr) Nouveaux derives de la methoxycarbonyl-2 n,n(prime)-di-(trimethoxybenzoyle) piperazine, ainsi que leur procede de preparation
DE3873139D1 (de) Derivat von d.25, verfahren zur herstellung, verwendung als immunostimulierendes mittel und pharmazeutische zusammensetzungen, welche diese enthalten.
ATE199556T1 (de) Verfahren zur fraktionierung von deacylierten glycerophospholipiden

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 466769

Country of ref document: ES